Published online Dec 6, 2022. doi: 10.12998/wjcc.v10.i34.12515
Peer-review started: May 5, 2022
First decision: July 14, 2022
Revised: August 6, 2022
Accepted: November 2, 2022
Article in press: November 2, 2022
Published online: December 6, 2022
Processing time: 211 Days and 8.1 Hours
Although illness perception is proposed to be associated with psychological health in patients with rheumatic diseases, empirical evidence is lacking to support this hypothesis. Furthermore, the contribution of ruminative coping style to this relationship is unclear yet.
Psychological symptoms observed in patients with rheumatic diseases in clinical practice.
This study aimed to investigate the association of illness perception and fatigue and negative emotions in patients with chronic rheumatic diseases and the potential mediating effects of rumination.
Illness perception, rumination, fatigue and negative emotions were assessed by the Illness Perception Questionnaire-Revised, Stress Reactive Rumination Scale, Multidimensional Assessment of Fatigue, and the Depression, Anxiety and Stress Scale respectively. Multivariate regression analysis, the Sobel test, and the bootstrap were used to identify the mediating effect of rumination.
All the subscales of illness perception were found significantly associated with fatigue and negative emotions. In mediational analysis, rumination mediated three components of illness perception (the identity, cyclical nature, and consequences of illness) and negative emotions/fatigue.
Perceived identity, cyclical nature, and consequences of illness are significantly associated with fatigue and negative emotions in patients with chronic rheumatic diseases and these associations are mediated by rumination. Psychological intervention should target rumination to improve physical and emotional well-being of patients with chronic rheumatic diseases.
Identification of the mediating role of rumination in the relationship between illness perception and negative emotions and fatigue has important implications clinically for developing cognitive interventions for patients with rheumatoid arthritis and systemic lupus erythematosus.
